PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer.
Qicai LiuLing GuoSheng ZhangJingwen WangXinhua LinFeng GaoPublished in: Molecular medicine (Cambridge, Mass.) (2019)
These findings suggested a novel pathway mediating pancreatic cancer development, with PRSS1 mutation and overexpression playing an "inside job" role in pancreatic carcinogenesis and tumor development.